Cue Biopharma Market Sentiment

Cue Biopharma Inc

CUENASDAQ

$26.20

0.501.95%

Últ. Act.: Aug 19, 1:38 PM

Ganancias: Los beneficios de Q2 2026 se publicaron el vie ago 14th, después del cierre del mercado

Market sentiment signals for Cue Biopharma (CUE): analyst consensus, short interest, options flow and insider activity.

Analyst Consensus▲ Buy

Short Interest▼ 9.1% short float

Options Flow— N/A

Insider Activity— Neutral (30d)

Analyst Consensus

Buy

7 analysts

Options Flow (P/C)

—

Avg Consensus PT

-83.1%

Highest Price Target

$10

-61.8%

Oppenheimer

Lowest Price Target

-92.4%

Citizens Capital Markets

Short Interest

9.1%

Rising — Bearish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 25, 2025	LUCID CAPITAL MARKETS	Dev Prasad —	-84.7%	$4	Initiate	Buy
Apr 2, 2025	Citizens Capital Markets	Reni Benjamin—	-92.4%	$2 → $2	Maintained	Market Outperform
Aug 20, 2024	Stifel	Stephen Willey—	-84.7%	$8 → $4	Maintained	Buy
Jul 26, 2024	JMP Securities	Reni Benjamin—	-92.4%	$15 → $2	Maintained	Market Outperform
Jul 26, 2024	Piper Sandler	Edward Tenthoff—	-88.5%	$8 → $3	Maintained	Overweight
Apr 9, 2024	Stifel	Stephen Willey—	-69.5%	$8 → $8	Maintained	Buy
Apr 9, 2024	Oppenheimer	Leland Gershell—	-61.8%	$10 → $10	Maintained	Outperform
Apr 3, 2024	Piper Sandler	Edward Tenthoff—	-69.5%	$8 → $8	Maintained	Overweight
Mar 13, 2024	Jefferies	Maury Raycroft—	-77.1%	$6	Initiate	Buy
Nov 6, 2023	Piper Sandler	Edward Tenthoff—	-69.5%	$7 → $8	Maintained	Overweight